# A Study to Investigate the Relative Bioavailability and Food Effect of Tablet for Oral Suspension of Sonrotoclax in Healthy Adults

> **NCT07628881** · PHASE1 · RECRUITING · sponsor: **BeOne Medicines** · enrollment: 12 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Sonrotoclax Tablet for Oral Suspension
- **DRUG:** Sonrotoclax Tablet

## Key facts

- **NCT ID:** NCT07628881
- **Lead sponsor:** BeOne Medicines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-17
- **Primary completion:** 2026-09-27
- **Final completion:** 2026-09-27
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07628881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07628881, "A Study to Investigate the Relative Bioavailability and Food Effect of Tablet for Oral Suspension of Sonrotoclax in Healthy Adults". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07628881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*